MAPK3 and neoplasm: G-1 induced sustained ERK1/2 activation has also been observed in prostate,16 breast,46 and tumor Leydig cells.30 Phosphorylated ERK1/2 can translocate from the cytoplasm to the nucleus, which is observed in SkBr3 cells treated with G-1 (Figure 5c).